跳至主要内容
临床试验/NL-OMON24637
NL-OMON24637尚未招募不适用

Randomized controlled trial of magnesium sulfate versus placebo on the prevention of atrial fibrillation post cardiac surgery.

one0 个研究点目标入组 812 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
one
入组人数
812

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Elective cardiac surgery (valve surgery and/or CABG)
  • -18 years and above

排除标准

  • -History of atrial fibrillation (AF) and atrial flutter
  • -Concomitant procedures (MAZE (surgical ablation)/PVI (pulmonary vein isolation))
  • -Pre-existing severe renal impairment (eGFR<30 ml/min) or development of oliguria post-surgery (<200 ml in previous 6 hours) and/or rise in creatinine with eGFR <30 ml/min)
  • -Significant hypotension persisting for 1 hour or longer (Noradrenaline >0.1 mcg/kg/min)
  • - Third-degree heart block without pacemaker in situ

研究者

发起方
one

相似试验